U Access (IRL) Nexthera UCITS

Overview

Fund Strategy Equity Long / Short
Fund Geography Global
Investment Advisor Nexthera Capital LP
Portfolio Manager Rael Mazansky
Fund Currency GBP
Fund AUM £91.5m
Fund AUM as of 30 April 2018
Fund Inception 05 July 2017
Fund Indices AH Equity Long / Short UCITS Index
Sub Index - Equity Long / Short Directional

Fund Objective

U Access (IRL) NEXTHERA UCITS (« the Fund ») is a Long/Short Equity fund allocating capital opportunistically and dynamically across the global healthcare sector, with an emphasis on therapeutics. The objective is to achieve absolute returns through long and short investments primarily in publicly traded equity securities in the pharma and biotech sub-sectors. The identification of investment opportunities across market capitalisations and geographies is based on thorough scientific and financial analysis. The portfolio comprises 40 to 50 liquid positions; its net exposure is dynamically managed and can vary over time. Risk management is a key component of the strategy as the healthcare sector could show high levels of volatility from time to time.

Teaser@2x

Register for free to access the full profile

Register (free)